The Osmanthus fragrans flower (OFF) is commonly used as an additive for tea in China and as a traditional medicine to treat dysentery, asthma and hepatitis. In the current study, we have acquired the aqueous extract of the dried OFF (OFFE) and determined its enriched acteoside contents. However, whether OFFE and acteoside can modulate melanogenesis and pigmentation has yet to be determined. We here provide novel data revealing that OFFE and acteoside inhibit melanogenesis induced by α-MSH in B16 melanoma cells via the MITF-tyrosinase signaling pathway. Treatment with α-MSH (1μM) enhanced melanin levels and tyrosinase activity, up-regulated the mRNA levels of MITF and tyrosinase and increased the dendritic number in B16 melanoma cells, effects all being intervened by OFFE and acteoside. Of interest, OFFE and acteoside showed no direct inhibition of tyrosinase activity as revealed by our ex vivo tyrosinase activity assay. In addition, OFFE produced a depigmenting action on UVB-induced hyperpigmentation in guinea pigs, as shown by the improved skin brightness and the decreased melanin staining. Our data have demonstrated that OFFE can alter melanogenesis via modulating the MITF-tyrosinase signaling thereby leading to its depigmenting action in the in vivo model. OFFE could be a substitute for acteoside as a promising skin-whitening agent.
HungC.Y., HuangF.L., ShiL.S., KaS.M., WangJ.Y., TsaiY.C., HungT.J., YeY.L. (2013) The ethanol extract of Osmanthus fragrans flowers reduces oxidative stress and allergic airway inflammation in an animal model. Evidience-Based Complementary and Alternative Medicine, 2013, 304290.
2.
HungC.Y., TsaiY.C., LiK.Y. (2012) Phenolic antioxidants isolated from the flowers of Osmanthus fragrans. Molecules, 17, 10724–10737.
3.
LeeH.H., LinC.T., YangL.L. (2007) Neuroprotection and free radical scavenging effects of Osmanthus fragrans. Journal of Biomedical Science, 14, 819–827.
4.
NakamuraS., LiuJ., NakashimaS., OgawaK., UedaT., OnishiE., KurookaK., MoriwakiY., RyuK., XuB., MatsumotoT., OhtaT., FukayaM., YoshikawaM., MatsudaH. (2016) Structure of a Coumaric acid analogue with a monoterpene moiety from the flowers of Osmanthus fragrans var. aurantiacus and evaluation of Cinnamic acid analogues as nitric oxide production and degranulation inhibitors. Natural Product Communications, 11, 1123–1128.
5.
LeeT.H., SeoJ.O., BaekS.H., KimS.Y. (2014) Inhibitory effects of resveratrol on melanin synthesis in ultraviolet B-induced pigmentation in Guinea pig skin. Biomolecules & Therapeutics (Seoul), 22, 35–40.
6.
ChoiS.Y., KimY.C. (2011) Whitening effect of black tea water extract on brown Guinea pig skin. Toxicology Research, 27, 153–160.
7.
SonY.O., LeeS.A., KimS.S., JangY.S., ChunJ.C., LeeJ.C. (2011) Acteoside inhibits melanogenesis in B16F10 cells through ERK activation and tyrosinase down-regulation. Journal of Pharmacy and Pharmacology, 63, 1309–1319.
8.
Bonmati-CarrionM.A., Alvarez-SanchezN., HardelandR., MadridJ.A., RolM.A. (2013) A comparison of B16 melanoma cells and 3T3 fibroblasts concerning cell viability and ROS production in the presence of melatonin, tested over a wide range of concentrations. International Journal of Molecular Sciences, 14, 3901–3920.
9.
CostinG.E., HearingV.J. (2007) Human skin pigmentation: melanocytes modulate skin color in response to stress. The FASEB Journal, 21, 976–994.
10.
LiangC.H., ChouT.H., DingH.Y. (2010) Inhibition of melanogensis by a novel origanoside from Origanum vulgare. Journal of Dermatological Science, 57, 170–177.
11.
JimbowK., QuevedoW.C., FitzpatrickT.B., SzaboG. (1993) Biology of melanocytes. Dermatology in general medicine, FitzpatrickTB (Ed). McGraw-Hill, New York, 261–288.
12.
TakeyamaR., TakekoshiS., NagataH., OsamuraR.Y., KawanaS. (2004) Quercetin-induced melanogenesis in a reconstituted three-dimensional human epidermal model. Journal of Molecular Histology, 35, 157–165.
13.
TagashiraH., MiyamotoA., KitamuraS., TsubataM., YamaguchiK., TakagakiK., ImokawaG. (2015) UVB stimulates the expression of endothelin B receptor in human melanocytes via a sequential activation of the p38/MSK1/CREB/MITF pathway which can be interrupted by a French maritime pine bark extract through a direct inactivation of MSK1. PLoS One, 10, e0128678.
14.
SpencerJ.D., ChavanB., MarlesL.K., KauserS., RokosH., SchallreuterK.U. (2005) A novel mechanism in control of human pigmentation by {beta}-melanocyte-stimulating hormone and 7-tetrahydrobiopterin. Journal of Endocrinology, 187, 293–302.
15.
SlominskiA., TobinD.J., ShibaharaS., WortsmanJ. (2004) Melanin pigmentation in mammalian skin and its hormonal regulation. Physiological Reviews, 84, 1155–1228.
16.
ParvezS., KangM., ChungH.S., ChoC., HongM.C., ShinM.K., BaeH. (2006) Survey and mechanism of skin depigmenting and lightening agents. Phytotherapy Research, 20, 921–934.
17.
BoisnicS., Branchet-GumilaM.C., NoceraT., VerriereF. (2005) RALGA (Diacneal) decreases melanin content in a human skin model. Dermatology, 210, Suppl 1, 35–38.
18.
BohmM., HillH.Z. (2016) Ultraviolet B, melanin and mitochondrial DNA: Photo-damage in human epidermal keratinocytes and melanocytes modulated by alpha-melanocyte-stimulating hormone. F1000Research, 5, 881.
19.
ChenY.S., LeeS.M., LinC.C., LiuC.Y. (2014) Hispolon decreases melanin production and induces apoptosis in melanoma cells through the downregulation of tyrosinase and microphthalmia-associated transcription factor (MITF) expressions and the activation of caspase-3, -8 and -9. International Journal of Molecular Sciences, 15, 1201–1215.
20.
RohE., YunC.Y., Young YunJ., ParkD., Doo KimN., Yeon HwangB., JungS.H., ParkS.K., KimY.B., HanS.B., KimY. (2013) cAMP-binding site of PKA as a molecular target of bisabolangelone against melanocyte-specific hyperpigmented disorder. Journal of Investigative Dermatology, 133, 1072–1079.
21.
SchallreuterK.U., KothariS., ChavanB., SpencerJ.D. (2008) Regulation of melanogenesis–controversies and new concepts. Experimental Dermatology, 17, 395–404.
22.
ShinH., HongS.D., RohE., JungS.H., ChoW.J., ParkS.H., YoonD.Y., KoS.M., HwangB.Y., HongJ.T., HeoT.Y., HanS.B., KimY. (2015) cAMP-dependent activation of protein kinase A as a therapeutic target of skin hyperpigmentation by diphenylmethylene hydrazinecarbothioamide. British Journal of Pharmacology, 172, 3434–3445.
23.
GuX., NylanderE., CoatesP.J., NylanderK. (2015) Oxidation reduction is a key process for successful treatment of psoriasis by narrow-band UVB phototherapy. Acta Dermato-Venereologica, 95, 140–146.
24.
JungH., ChungH., ChangS.E., KangD.H., OhE.S. (2016) FK506 regulates pigmentation by maturing the melanosome and facilitating their transfer to keratinocytes. Pigment Cell & Melanoma Research, 29, 199–209.
